Therapeuticsmd

Therapeuticsmd company information, Employees & Contact Information

Explore related pages

Related company profiles:

TherapeuticsMD, Inc. is an innovative pharmaceutical company exclusively committed to advancing the health of women and championing awareness of their health care issues. We create products to address the unique changes and challenges women experience through every stage of their lives. With momentum fueled by the needs of our customers, we combine entrepreneurial spirit and clinical expertise to develop innovative solutions designed to go beyond what is presently available. This includes a variety of therapies in our pipeline, along with prescription prenatal vitamins under the vitaMedMD® and BocaGreenMD® brands. See our community guidelines: https://www.therapeuticsmd.com/social-media-community-guidelines

Company Details

Employees
53
Address
951 Yamato Rd,
Phone
561-961-1900
Email
in****@****smd.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Boca Raton, Florida
Looking for a particular Therapeuticsmd employee's phone or email?

Therapeuticsmd Questions

News

TherapeuticsMD Announces First Quarter 2025 Financial Results - Business Wire

TherapeuticsMD Announces First Quarter 2025 Financial Results Business Wire

TherapeuticsMD Inc. (TXMD) reports earnings - qz.com

TherapeuticsMD Inc. (TXMD) reports earnings qz.com

TherapeuticsMD CEO Marlan Walker buys $489 in common stock - Investing.com

TherapeuticsMD CEO Marlan Walker buys $489 in common stock Investing.com

TherapeuticsMD, An Innovative Women's Healthcare Company, And PlushCare, A Virtual Health Platform, Announce Enhanced Access To Women's Health Products - PR Newswire

TherapeuticsMD, An Innovative Women's Healthcare Company, And PlushCare, A Virtual Health Platform, Announce Enhanced Access To Women's Health Products PR Newswire

TherapeuticsMD lays off entire workforce after licensing products out for $153M - Fierce Pharma

TherapeuticsMD lays off entire workforce after licensing products out for $153M Fierce Pharma

TherapeuticsMD Announces Expiration of Tender Offer - Stock Titan

TherapeuticsMD Announces Expiration of Tender Offer Stock Titan

TherapeuticsMD Appoints Hugh O’Dowd as President - citybiz

TherapeuticsMD Appoints Hugh O’Dowd as President citybiz

TherapeuticsMD buyout unravels as shareholders balk - BioPharma Dive

TherapeuticsMD buyout unravels as shareholders balk BioPharma Dive

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause - News-Medical

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause News-Medical

Aug Technicals: How TherapeuticsMD Inc. (29TA) stock responds to bond market - Bull Run & Stepwise Trade Signal Implementation - Trung tâm Dự báo KTTV quốc gia

Aug Technicals: How TherapeuticsMD Inc. (29TA) stock responds to bond market - Bull Run & Stepwise Trade Signal Implementation Trung tâm Dự báo KTTV quốc gia

Bijuva From TherapeuticsMD - Pharmacy Times

Bijuva From TherapeuticsMD Pharmacy Times

TherapeuticsMD to lay off entire staff after $153M licensing deal with Mayne Pharma - Medical Marketing and Media

TherapeuticsMD to lay off entire staff after $153M licensing deal with Mayne Pharma Medical Marketing and Media

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors MarketWatch

TherapeuticsMD to offload drugs to Australia’s Mayne after failed buyout - BioPharma Dive

TherapeuticsMD to offload drugs to Australia’s Mayne after failed buyout BioPharma Dive

TherapeuticsMD (NASDAQ:TXMD) investors are sitting on a loss of 90% if they invested five years ago - Yahoo Finance

TherapeuticsMD (NASDAQ:TXMD) investors are sitting on a loss of 90% if they invested five years ago Yahoo Finance

Can TherapeuticsMD Inc. (29TA) stock ride next bull market cycle - 2025 AllTime Highs & Long-Term Capital Growth Ideas - Trung tâm Dự báo KTTV quốc gia

Can TherapeuticsMD Inc. (29TA) stock ride next bull market cycle - 2025 AllTime Highs & Long-Term Capital Growth Ideas Trung tâm Dự báo KTTV quốc gia

Is TherapeuticsMD Inc. stock cheap at current valuation - Market Activity Recap & Safe Investment Capital Preservation Plans - Trung tâm Dự báo KTTV quốc gia

Is TherapeuticsMD Inc. stock cheap at current valuation - Market Activity Recap & Safe Investment Capital Preservation Plans Trung tâm Dự báo KTTV quốc gia

Biotech layoffs claim more jobs at Sensei, Instil, TherapeuticsMD - BioPharma Dive

Biotech layoffs claim more jobs at Sensei, Instil, TherapeuticsMD BioPharma Dive

Comedian Whitney Cummings Partners with TherapeuticsMD to Launch "Just Say Vagina" - Nasdaq

Comedian Whitney Cummings Partners with TherapeuticsMD to Launch "Just Say Vagina" Nasdaq

TherapeuticsMD: Q3 Earnings Snapshot - qz.com

TherapeuticsMD: Q3 Earnings Snapshot qz.com

Therapeuticsmd finds licensing partner in $140M Mayne deal - BioWorld MedTech

Therapeuticsmd finds licensing partner in $140M Mayne deal BioWorld MedTech

Why I started a pharmaceutical company - Contemporary OB/GYN

Why I started a pharmaceutical company Contemporary OB/GYN

TXMD Stock Price and Chart — NASDAQ:TXMD - TradingView

TXMD Stock Price and Chart — NASDAQ:TXMD TradingView

TherapeuticsMD: From Fallen And Forgotten To Cash Cow - Seeking Alpha

TherapeuticsMD: From Fallen And Forgotten To Cash Cow Seeking Alpha

3 Promising US Penny Stocks With Over $9M Market Cap - simplywall.st

3 Promising US Penny Stocks With Over $9M Market Cap simplywall.st

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors MarketWatch

Investment Report: How TherapeuticsMD Inc. (29TA) stock responds to bond market - July 2025 Patterns & Reliable Intraday Trade Alerts - Trung tâm Dự báo KTTV quốc gia

Investment Report: How TherapeuticsMD Inc. (29TA) stock responds to bond market - July 2025 Patterns & Reliable Intraday Trade Alerts Trung tâm Dự báo KTTV quốc gia

Can TherapeuticsMD Inc. (29TA) stock ride next bull market cycle - July 2025 Momentum & Comprehensive Market Scan Reports - Trung tâm Dự báo KTTV quốc gia

Can TherapeuticsMD Inc. (29TA) stock ride next bull market cycle - July 2025 Momentum & Comprehensive Market Scan Reports Trung tâm Dự báo KTTV quốc gia

TherapeuticsMD Inc. stock falls Thursday, underperforms market - MarketWatch

TherapeuticsMD Inc. stock falls Thursday, underperforms market MarketWatch

Campaign: IMVEXXY | Long May She Reign - Modern Healthcare News

Campaign: IMVEXXY | Long May She Reign Modern Healthcare News

How TherapeuticsMD Inc. (29TA) stock reacts to weak economy - Fed Meeting & Growth Focused Stock Reports - Trung tâm Dự báo KTTV quốc gia

How TherapeuticsMD Inc. (29TA) stock reacts to weak economy - Fed Meeting & Growth Focused Stock Reports Trung tâm Dự báo KTTV quốc gia

TherapeuticsMD Inc. stock falls Friday, still outperforms market - MarketWatch

TherapeuticsMD Inc. stock falls Friday, still outperforms market MarketWatch

TherapeuticsMD Inc. stock outperforms market on strong trading day - MarketWatch

TherapeuticsMD Inc. stock outperforms market on strong trading day MarketWatch

TherapeuticsMD Inc. stock falls Monday, underperforms market - MarketWatch

TherapeuticsMD Inc. stock falls Monday, underperforms market MarketWatch

$300M loan boosts launch of TherapeuticsMD hot flash pill - BioPharma Dive

$300M loan boosts launch of TherapeuticsMD hot flash pill BioPharma Dive

TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXYTM (estradiol vaginal - MultiVu

TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXYTM (estradiol vaginal MultiVu

Why TherapeuticsMD Inc. stock is seen as undervalued - Sell Signal & Safe Entry Zone Identification - Fundação Cultural do Pará

Why TherapeuticsMD Inc. stock is seen as undervalued - Sell Signal & Safe Entry Zone Identification Fundação Cultural do Pará

Bio-Identical Combo Therapy Promising for Vasomotor Symptoms of Menopause - Medical Professionals Reference

Bio-Identical Combo Therapy Promising for Vasomotor Symptoms of Menopause Medical Professionals Reference

TherapeuticsMD Stock Is a Good Buy Despite Losses - Market Realist

TherapeuticsMD Stock Is a Good Buy Despite Losses Market Realist

TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital - FinancialContent

TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital FinancialContent

Down 70% in 2021, is Now a Good Time to Scoop Up Shares of TherapeuticsMD? - Entrepreneur

Down 70% in 2021, is Now a Good Time to Scoop Up Shares of TherapeuticsMD? Entrepreneur

TherapeuticsMD CEO Robert Finizio Finds A Niche In Pharma - ChiefExecutive.net

TherapeuticsMD CEO Robert Finizio Finds A Niche In Pharma ChiefExecutive.net

TherapeuticsMD hires CFO from multibillion-dollar pharma giant - The Business Journals

TherapeuticsMD hires CFO from multibillion-dollar pharma giant The Business Journals

TherapeuticsMD gears up to launch first-ever bioidentical hormone combo Bijuva - Fierce Pharma

TherapeuticsMD gears up to launch first-ever bioidentical hormone combo Bijuva Fierce Pharma

TherapeuticsMD launches Rx prenatal that's certified vegan and certified kosher - Drug Store News

TherapeuticsMD launches Rx prenatal that's certified vegan and certified kosher Drug Store News

Power Leaders in Health Care - The Business Journals

Power Leaders in Health Care The Business Journals

Top Therapeuticsmd Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant